Pharvaris is now gearing up startup activities with clinical site investigators and staff to launch a Phase 3 trial…
Articles by Margarida Maia, PhD
A 58-year-old woman developed angioedema of the small bowel after three years of taking lisinopril, an angiotensin-converting enzyme (ACE)…
Children with hereditary angioedema (HAE) may have dozens of swelling attacks until they receive a correct diagnosis of…
A 3-point score increase is the minimum change on the widely used Angioedema Control Test (AECT) to reflect meaningful improvement…
On-demand and preventive treatment with either icatibant injection or C1 inhibitor (C1-INH) concentrates — which are approved for hereditary angioedema (HAE)…
People who develop angioedema due to common high blood pressure medications known as angiotensin-converting enzyme (ACE) inhibitors may be…
Takhzyro (lanadelumab) may be better than Cinryze at preventing swelling episodes in hereditary angioedema (HAE), according to…
Treatment with tranexamic acid may ease symptoms and prevent intubation in people who develop angioedema after receiving certain…
The U.S. Food and Drug Administration (FDA) has given STAR-0215 fast track status to help speed up its development…
Pharvaris’ PHVS416, a soft-gel capsule of PHA121, now also known as deucrictibant, continues to show promising safety and effectiveness…